Diovan · DIN 02289504 · 320 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Diovan · DIN 02289504
Manufacturer: Novartis Pharma Canada Inc.; listing date 2008-02-12
Health Canada: Marketed since 2007-02-14 · brand DIOVAN · ATC C09CA03 VALSARTAN · form Tablet · route Oral · ingredients VALSARTAN 320 MG · company Novartis pharmaceuticals canada inc · schedule Prescription
Ministry pays: $0.2098 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02289504)
Source record
DIN 02289504: Diovan
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240800272; group id 357; item number 0831; lccId None; manufacturer id NOV
Source form: Tab; strength: 320mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.5124; ministry $0.2098
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02289504
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77486
Interchangeable products
Apo-Valsartan · DIN 02371545 · $0.2098
Auro-Valsartan · DIN 02414244 · $0.2098
Co Valsartan · DIN 02337517 · $0.2098
Sandoz Valsartan · DIN 02356775 · $0.2098
Teva-Valsartan · DIN 02356686 · $0.2098
Valsartan · DIN 02366975 · $0.2098
Valsartan · DIN 02384566 · $0.2098
Shortage status: resolved shortage (ended April 30, 2020); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02289504
Shortage record checked October 6, 2026